FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2737190756> ?p ?o ?g. }

• W2737190756 endingPage "944" @default.
• W2737190756 startingPage "937" @default.
• W2737190756 abstract "Background:A consensus statement recommends initial intravenous (IV) vancomycin dosing of 15-20 mg/kg every 8- 24 hours, with an optional 25- to 30-mg/kg loading dose. Although some studies have shown an association between weight and the development of vancomycin-associated nephrotoxicity, results have been inconsistent. Objective: To evaluate the correlation between incidence of nephrotoxicity associated with weight-based IV vancomycin dosing strategies in nonobese and obese patients. Methods: This retrospective cohort study evaluated hospitalized adult patients admitted who received IV vancomycin. Patients were stratified into nonobese (body mass index [BMI] <25 kg/m 2 ), obesity class I and II (BMI 30-39.9kg/m 2 ), and obesity class III (BMI≥40 kg/m 2 ) groups; patients who were overweight but not obese were excluded. Incidence of nephrotoxicity and serum vancomycin trough concentrations were evaluated. Results: Of a total of 62 documented cases of nephrotoxicity (15.1%), 13 (8.7%), 23 (14.3%), and 26 (26.3%) cases were observed in nonobese, obesity class I and II, and obesity class III groups, respectively ( P=0.002). Longer durations of therapy ( P<0.0001), higher initial maintenance doses in both total milligrams/day ( P=0.0137) and milligrams/kilogram ( P=0.0307), and any trough level >20 mg/L ( P<0.0001) were identified as predictors of development of nephrotoxicity. Concomitant administration of piperacillin/tazobactam, diuretics, and IV contrast were associated with development of nephrotoxicity ( P<0.005, all). Patients with class III obesity were 3-times as likely to develop nephrotoxicity when compared with nonobese patients (odds ratio [OR]=2.99; CI=1.12-7.94) and obesity class I and II patients (OR=3.14; CI=1.27-7.75). Conclusions: Obesity and other factors are associated with a higher risk of vancomycin-associated nephrotoxicity." @default.
• W2737190756 created "2017-07-31" @default.
• W2737190756 creator A5004207937 @default.
• W2737190756 creator A5018448300 @default.
• W2737190756 creator A5020980206 @default.
• W2737190756 creator A5029020838 @default.
• W2737190756 creator A5029144465 @default.
• W2737190756 creator A5029566181 @default.
• W2737190756 creator A5037031522 @default.
• W2737190756 creator A5043771930 @default.
• W2737190756 creator A5077828368 @default.
• W2737190756 creator A5083258702 @default.
• W2737190756 date "2017-07-14" @default.
• W2737190756 modified "2023-09-30" @default.
• W2737190756 title "Intravenous Vancomycin Associated With the Development of Nephrotoxicity in Patients With Class III Obesity" @default.
• W2737190756 cites W1825420268 @default.
• W2737190756 cites W1831522254 @default.
• W2737190756 cites W1882385045 @default.
• W2737190756 cites W2011312924 @default.
• W2737190756 cites W2051651842 @default.
• W2737190756 cites W2053473446 @default.
• W2737190756 cites W2108039951 @default.
• W2737190756 cites W2111442039 @default.
• W2737190756 cites W2116736766 @default.
• W2737190756 cites W2133120422 @default.
• W2737190756 cites W2140147718 @default.
• W2737190756 cites W2144863467 @default.
• W2737190756 cites W2152771638 @default.
• W2737190756 cites W2158657903 @default.
• W2737190756 cites W2552795391 @default.
• W2737190756 cites W2577202196 @default.
• W2737190756 doi "https://doi.org/10.1177/1060028017720946" @default.
• W2737190756 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28709394" @default.
• W2737190756 hasPublicationYear "2017" @default.
• W2737190756 type Work @default.
• W2737190756 sameAs 2737190756 @default.
• W2737190756 citedByCount "30" @default.
• W2737190756 countsByYear W27371907562017 @default.
• W2737190756 countsByYear W27371907562018 @default.
• W2737190756 countsByYear W27371907562019 @default.
• W2737190756 countsByYear W27371907562020 @default.
• W2737190756 countsByYear W27371907562021 @default.
• W2737190756 countsByYear W27371907562022 @default.
• W2737190756 countsByYear W27371907562023 @default.
• W2737190756 crossrefType "journal-article" @default.
• W2737190756 hasAuthorship W2737190756A5004207937 @default.
• W2737190756 hasAuthorship W2737190756A5018448300 @default.
• W2737190756 hasAuthorship W2737190756A5020980206 @default.
• W2737190756 hasAuthorship W2737190756A5029020838 @default.
• W2737190756 hasAuthorship W2737190756A5029144465 @default.
• W2737190756 hasAuthorship W2737190756A5029566181 @default.
• W2737190756 hasAuthorship W2737190756A5037031522 @default.
• W2737190756 hasAuthorship W2737190756A5043771930 @default.
• W2737190756 hasAuthorship W2737190756A5077828368 @default.
• W2737190756 hasAuthorship W2737190756A5083258702 @default.
• W2737190756 hasConcept C120665830 @default.
• W2737190756 hasConcept C121332964 @default.
• W2737190756 hasConcept C126189478 @default.
• W2737190756 hasConcept C126322002 @default.
• W2737190756 hasConcept C126894567 @default.
• W2737190756 hasConcept C141071460 @default.
• W2737190756 hasConcept C2777288759 @default.
• W2737190756 hasConcept C2778980435 @default.
• W2737190756 hasConcept C2779489039 @default.
• W2737190756 hasConcept C2780221984 @default.
• W2737190756 hasConcept C2780586474 @default.
• W2737190756 hasConcept C29730261 @default.
• W2737190756 hasConcept C511355011 @default.
• W2737190756 hasConcept C523546767 @default.
• W2737190756 hasConcept C54355233 @default.
• W2737190756 hasConcept C61511704 @default.
• W2737190756 hasConcept C71924100 @default.
• W2737190756 hasConcept C86803240 @default.
• W2737190756 hasConcept C90924648 @default.
• W2737190756 hasConceptScore W2737190756C120665830 @default.
• W2737190756 hasConceptScore W2737190756C121332964 @default.
• W2737190756 hasConceptScore W2737190756C126189478 @default.
• W2737190756 hasConceptScore W2737190756C126322002 @default.
• W2737190756 hasConceptScore W2737190756C126894567 @default.
• W2737190756 hasConceptScore W2737190756C141071460 @default.
• W2737190756 hasConceptScore W2737190756C2777288759 @default.
• W2737190756 hasConceptScore W2737190756C2778980435 @default.
• W2737190756 hasConceptScore W2737190756C2779489039 @default.
• W2737190756 hasConceptScore W2737190756C2780221984 @default.
• W2737190756 hasConceptScore W2737190756C2780586474 @default.
• W2737190756 hasConceptScore W2737190756C29730261 @default.
• W2737190756 hasConceptScore W2737190756C511355011 @default.
• W2737190756 hasConceptScore W2737190756C523546767 @default.
• W2737190756 hasConceptScore W2737190756C54355233 @default.
• W2737190756 hasConceptScore W2737190756C61511704 @default.
• W2737190756 hasConceptScore W2737190756C71924100 @default.
• W2737190756 hasConceptScore W2737190756C86803240 @default.
• W2737190756 hasConceptScore W2737190756C90924648 @default.
• W2737190756 hasIssue "11" @default.
• W2737190756 hasLocation W27371907561 @default.
• W2737190756 hasLocation W27371907562 @default.
• W2737190756 hasOpenAccess W2737190756 @default.
• W2737190756 hasPrimaryLocation W27371907561 @default.

• next